RecruitingPhase 1ketamine

Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries

Sponsored by Cairo University

NCT ID
NCT06545890
Target Enrollment
46 participants
Start Date
2024-08-10
Est. Completion
2024-11-10

About This Study

The aim of the study is to compare the effectiveness of ketofol for the prevention of emergence delirium in pediatric patients undergoing squint surgery, in comparison to dexmedetomidine.

Conditions Studied

Emergence Delirium

Interventions

  • •Ketamine
  • •Dexmedetomidine

Eligibility

Age:2 Years - 6 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* • All pediatric patients aged 2 to 6 years.

  * Both sexes.
  * ASA physical status I and II.
  * Patients undergoing squint surgery.

Exclusion Criteria:

* • Refusal of parents.

  * Patient sensitivity to any of the study medications.
  * Known neurological disease that can affect the assessment of ED postoperatively.

Study Locations (2)

Abu Elresh Hospitals ( Cairo university )
Cairo, Egypt
Abu ElResh hospital
Cairo, Egypt

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Muhammad Kh Ibrahim
CONTACT
+201032170260dr.mki26413@gmail.com
Mohamed El Abdelfatah
CONTACT
+201272288695mohyaseen2@gmail.com
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries | Huxley